Chinese regulators have intensified their crackdown on insurers’ use of high-risk, high-return products, which are often used to fund corporate deals.
manbetx3.0
监管机构加大了对保险公司利用高风险高回报产品的打击，这些产品往往被用于企业交易。
您已阅读5%（192字），剩余95%（3993字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。